股票代码
000661
About
Group introduction
Leading teams
Organizational chart
Enterprise culture
Development strategy
Honor qualification
Investment enterprise
Business
Pharmaceutical industry
Real-estate development
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of responsibility
Public welfare
CN
About
Group introduction
Leading teams
Organizational chart
Enterprise culture
Development strategy
Honor qualification
Investment enterprise
Business
Pharmaceutical industry
Real-estate development
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of responsibility
Public welfare
To stimulate the potential of life so that life blossomed in the hone
Investor
Periodical report
Company announcement
Interactive platform
CN
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Home
About
Group introduction
Leading teams
Organizational chart
Enterprise culture
Development strategy
Honor qualification
Investment enterprise
Business
Pharmaceutical industry
Real-estate development
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of responsibility
Public welfare
Total
2,045
announcements
第十届监事会第十一次会议决议公告
2022-09-30
中信建投证券、中天国富证券关于长春高新发行股份及可转换债券购买资产并募集配套资金暨关联交易之标的资产减值测试情况的核查意见
2022-09-30
重大资产重组标的资产减值测试专项审核报告
2022-09-30
第十届董事会第十八次会议决议公告
2022-09-30
独立董事关于第十届董事会第十七次会议相关事项的独立意见
2022-09-24
第十届董事会第十七次会议决议公告
2022-09-24
关于2022年限制性股票与股票期权激励计划限制性股票首次授予登记完成的公告
2022-09-22
关于控股子公司EG017片获得药物临床试验批准的公告
2022-09-22
关于2022年限制性股票与股票期权激励计划股票期权首次授予登记完成的公告
2022-09-14
半年度非经营性资金占用及其他关联资金往来情况汇总表
2022-08-26
2022年半年度报告
2022-08-26
独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
2022-08-26
2022年半年度财务报告
2022-08-26
2022年半年度报告摘要
2022-08-26
关于控股子公司GS3-007a口服液获得药物临床试验批准的公告
2022-08-19
上一页
17
18
19
20
21
22
23
24
25
26
27
下一页